Level Biotechnology Inc. (3118) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Level Biotechnology Inc. (3118:TWSE), powered by AI.

Current Price
$31.25
Sector
Healthcare
What is the Level Biotechnology Inc. stock price forecast?

Level Biotechnology Inc. is currently trading at $31.25. View real-time AI analysis on Alpha Lenz.

What is Level Biotechnology Inc. insider trading activity?

View the latest insider trading data for Level Biotechnology Inc. on Alpha Lenz.

What is Level Biotechnology Inc.'s P/E ratio?

View Level Biotechnology Inc.'s valuation metrics on Alpha Lenz.

Level Biotechnology Inc.

TWSE · 3118
NT$31.25-0.05(-0.16%)
Ask about Level Biotechnology Inc.'s future dividend policy...
Alpha Chat Insight

Level Biotechnology Inc.'s ROE is 14.0%. Explore profitability and growth together.

Ask for details

Company Overview

Level Biotechnology Inc. is a biotechnology company specializing in the marketing and distribution of cell culture, immunology, and molecular biology products, as well as biomedical precision equipment. Founded in 1989 and headquartered in New Taipei City, Taiwan, the company serves a wide range of clients in the biotechnology, pharmaceutical, medical device, animal health, and agrichemical industries. Notably, Level Biotechnology provides comprehensive preclinical contract research organization (CRO) services, including genetic toxicology, mammalian toxicology, pharmacology, biocompatibility, and model animal production. With over nine thousand square yards of laboratory space and internationally accredited animal facilities, the company adheres to rigorous standards such as Good Laboratory Practice (GLP) and ISO 17025. This combination of product distribution and high-quality testing services positions Level Biotechnology Inc. as a significant player supporting biomedical research, product development, and regulatory compliance in Taiwan’s healthcare and life sciences sectors.

SectorHealthcare
IndustryBiotechnology
Employees132

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$736.59MRevenue
0.00Shares Out
132Employees

Margins

34.99%Gross
16.32%EBITDA
11.34%Operating
13.25%Pre-Tax
10.82%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

7.49%Rev 3Yr
1.84%Rev 5Yr
8.77%Op Inc 3Yr
4.77%Op Inc 5Yr
10.88%Net Inc 3Yr
6.55%Net Inc 5Yr

Returns

9.41%ROA
13.98%ROE
11.54%ROIC

Financial Health

NT$210.34MCash & Cash Equivalents
NT$76.29MNet Debt
49.40%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Level Biotechnology Inc. (ticker: 3118) is a company listed on TWSE in the Healthcare sector (Biotechnology). It has approximately 132 employees.

The current price is 31.25 with a P/E ratio of -x and P/B of -x.

ROE is 13.98% and operating margin is 11.34%. Annual revenue is $737M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Level Biotechnology Inc. (3118) Stock Forecast 2026 $31.25 — Price, Financials & Analyst Targets | Alpha Lenz